FR2537584B1 - Pyrazoloquinoleines substituees particulieres, procede pour leur preparation, preparations pharmaceutiques contenant ces composes et leur application therapeutique - Google Patents

Pyrazoloquinoleines substituees particulieres, procede pour leur preparation, preparations pharmaceutiques contenant ces composes et leur application therapeutique

Info

Publication number
FR2537584B1
FR2537584B1 FR8319492A FR8319492A FR2537584B1 FR 2537584 B1 FR2537584 B1 FR 2537584B1 FR 8319492 A FR8319492 A FR 8319492A FR 8319492 A FR8319492 A FR 8319492A FR 2537584 B1 FR2537584 B1 FR 2537584B1
Authority
FR
France
Prior art keywords
pyrazoloquinoleins
compounds
preparation
pharmaceutical preparations
preparations containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8319492A
Other languages
English (en)
Other versions
FR2537584A1 (fr
Inventor
Naokata Yokoyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of FR2537584A1 publication Critical patent/FR2537584A1/fr
Application granted granted Critical
Publication of FR2537584B1 publication Critical patent/FR2537584B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR8319492A 1982-12-08 1983-12-06 Pyrazoloquinoleines substituees particulieres, procede pour leur preparation, preparations pharmaceutiques contenant ces composes et leur application therapeutique Expired FR2537584B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/447,825 US4524146A (en) 1982-12-08 1982-12-08 Certain -2-heterocycle substituted pyrazoloquinolines

Publications (2)

Publication Number Publication Date
FR2537584A1 FR2537584A1 (fr) 1984-06-15
FR2537584B1 true FR2537584B1 (fr) 1987-01-16

Family

ID=23777905

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8319492A Expired FR2537584B1 (fr) 1982-12-08 1983-12-06 Pyrazoloquinoleines substituees particulieres, procede pour leur preparation, preparations pharmaceutiques contenant ces composes et leur application therapeutique

Country Status (9)

Country Link
US (1) US4524146A (fr)
JP (1) JPS59110694A (fr)
BE (1) BE898383A (fr)
CH (1) CH656127A5 (fr)
DE (1) DE3343922A1 (fr)
FR (1) FR2537584B1 (fr)
GB (1) GB2131801B (fr)
IT (1) IT1205349B (fr)
NL (1) NL8304224A (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549833B1 (fr) * 1983-07-26 1985-11-08 Roussel Uclaf Derives de la pyrazolo /4,3-c/ cinnolin-3-one, leurs sels, procede de preparation, application a titre de medicaments, compositions les renfermant et produits intermediaires
CA1263651A (fr) * 1984-07-09 1989-12-05 Ciba-Geigy Ag Certains derives de pyrazolo¬3,4-d|-pyridin-3- one a noyaux condenses
US4602014A (en) * 1984-07-09 1986-07-22 Ciba-Geigy Corporation Ring-fused pyrazolo[3,4-d]-pyridin-3-one derivatives as benzodiazepine receptor modulators
PH21213A (en) * 1984-10-26 1987-08-21 Fujisawa Pharmaceutical Co Benzene- and pyrazole- fused heterocyclic compound and pharmaceutical composition comprising the same
JPS61112075A (ja) * 1984-11-05 1986-05-30 Shionogi & Co Ltd チエニルピラゾロキノリン誘導体
US4591589A (en) * 1985-01-16 1986-05-27 Roussel Uclaf 2-aryl pyrazolo[4,3-c]cinnolin-3-ones
US4758427A (en) * 1985-08-08 1988-07-19 Ciba-Geigy Corporation Enhanced absorption of psychoactive 2-aryl-pyrazolo quinolines as a solid molecular dispersion in polyvinylpyrrolidone
US4831013A (en) * 1986-03-20 1989-05-16 Ciba-Geigy Corporation 2-substituted-e-fused-[1,2,4]triazolo[1,5-c]pyrimidines, pharmaceutical compositions, and uses thereof
US4826854A (en) * 1986-11-25 1989-05-02 Ciba-Geigy Corporation Certain cycloalka-(b)-pyrazolo(3,4-d)-pyridin-3-one derivatives
US5192768A (en) * 1990-09-14 1993-03-09 Kyowa Hakko Kogyo Co., Ltd. Pyrazoloquinoline derivatives
US5334595A (en) * 1992-10-23 1994-08-02 Sterling Winthrop Inc. Pyrazoloquinolones as anticancer agents
AR006520A1 (es) * 1996-03-20 1999-09-08 Astra Pharma Prod Derivados de 2-arilpirazolisoquinolina y cinolinona y procedimiento para su preparacion.
AU6019900A (en) * 1999-11-24 2001-06-04 Sumika Fine Chemicals Co., Ltd. Anhydrous mirtazapine crystals and process for producing the same
CN101686682A (zh) * 2007-06-08 2010-03-31 海利空医疗公司 治疗用吡唑并喹啉脲衍生物
US20110212053A1 (en) * 2008-06-19 2011-09-01 Dapeng Qian Phosphatidylinositol 3 kinase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2009079A1 (fr) * 1968-05-22 1970-01-30 Sandoz Sa
ATE8629T1 (de) * 1979-06-21 1984-08-15 Ciba-Geigy Ag Pyrazolochinoline, verfahren zu ihrer herstellung, und pharmazeutische praeparate enthaltend diese verbindungen.
US4312870A (en) * 1979-06-21 1982-01-26 Ciba-Geigy Corporation Pyrazoloquinolines

Also Published As

Publication number Publication date
FR2537584A1 (fr) 1984-06-15
NL8304224A (nl) 1984-07-02
GB8332274D0 (en) 1984-01-11
GB2131801B (en) 1986-01-22
DE3343922A1 (de) 1984-06-28
GB2131801A (en) 1984-06-27
IT1205349B (it) 1989-03-15
CH656127A5 (de) 1986-06-13
US4524146A (en) 1985-06-18
IT8349450A0 (it) 1983-12-06
BE898383A (fr) 1984-06-06
JPS59110694A (ja) 1984-06-26

Similar Documents

Publication Publication Date Title
PT77488A (fr) Procede de preparation de derives de phenyl-1-piperidino-2-propanol et de compositions pharmaceutiques les contenant
BE896986A (fr) Derives d'indole, procedes pour leur preparation et composition pharmaceutiques les contenant
MA18829A1 (fr) Derives de la pyrimidine,procedes pour leur preparation,compositions pharmaceutiques contenant ces composes et leur utilisation therapeutique
FR2471968B1 (fr) Ethers basiques, leur procede de preparation et compositions pharmaceutiques les contenant
FR2537584B1 (fr) Pyrazoloquinoleines substituees particulieres, procede pour leur preparation, preparations pharmaceutiques contenant ces composes et leur application therapeutique
FR2542740B1 (fr) Derives de thiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2522324B1 (fr) Pyrrole-acetamides, leur procede de preparation et composition therapeutique les contenant
BE885156A (fr) Psoralenes, leur procede de preparation et compositions pharmaceutiques les contenant
BE857289A (fr) 2-benzyl-pyrrolidines, procede pour leur preparation et medicaments contenant ces composes
OA07521A (fr) Nicotonamide 1-substitué, ses sels, procédé pour leur préparation et compositions pharmaceutiques en contenant.
FR2563519B1 (fr) Derives d'iminothiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant
BE885633A (fr) Derives de 1,2,4-oxadiazolin-5-one, procede pour leur preparation et compositions pharmaceutiques les contenant
MC1549A1 (fr) Anthracycline-glycosides,procede pour leur preparation et medicaments les contenant
MA19602A1 (fr) Composes d'amino-oxazolyle, procede pour leur preparation, preparations pharmaceutiques qui contiennent ces composes, et leur application
FR2551440B1 (fr) Aminocyclopentanes, leur procede de preparation et compositions pharmaceutiques les contenant
PT77767B (fr) Procede de preparation de 3',5'-diarabinosides et de compositi-ons pharmaceutiques les contenant
FR2315910A1 (fr) Compositions pharmaceutiques contenant de la " debrycine " heterocolloidale et procede pour leur preparation
FR2592043B1 (fr) 2-chloro-12-(3-dimethylamino-2-methylpropyl)-12h-dibenzo-(d, g) (1, 3, 6)-dioxazocines optiquement actives, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2530635B1 (fr) Composes d'amino-imidazolyle, procede pour leur preparation, preparations pharmaceutiques contenant ces composes, et application de ces dernieres
FR2529551B1 (fr) Derives d'eburnane-oxime, procede pour leur preparation et compositions pharmaceutiques contenant ces composes
FR2529549B1 (fr) Oxime-ethers d'eburnane, procede pour leur preparation et compositions pharmaceutiques qui les contiennent
FR2528829B1 (fr) Composes polyprenyliques, procedes pour leur preparation et composition therapeutique les contenant
FR2529550B1 (fr) Derives d'acide apovincaminique, procede pour leur preparation et compositions pharmaceutiques contenant ces derives
FR2527630B1 (fr) Enzyme leucocytaire humaine de type pepsique, procede pour sa preparation et agent therapeutique la contenant
FR2509305B1 (fr) Benzamides, procede pour leur preparation et compositions pharmaceutiques les renfermant

Legal Events

Date Code Title Description
ST Notification of lapse